The use and discontinuation of hormone replacement therapy in women in South China

References

• Mckinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103–15
   PubMed Web of Science ®Google Scholar
• Welton AJ, Vickers MR, Kim J, et al. Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ 2008;337:a1190
   PubMed Web of Science ®Google Scholar
• Zhu L, Jiang X, Sun Y, et al. Effect of hormone therapy on the risk of bone fractures: a systematic review and meta-analysis of randomized controlled trials. Menopause 2015;23:461–70
   Web of Science ®Google Scholar
• Schierbeck L. Primary prevention of cardiovascular disease with hormone replacement therapy. Climacteric 2015;18:492–7
   PubMed Web of Science ®Google Scholar
• Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605–13
   PubMed Web of Science ®Google Scholar
• Rossouw J, Anderson G, Prentice R, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Yang DD, Haines CJ, Pan P, et al. Menopausal symptoms in mid-life women in southern China. Climacteric 2008;11:329–36
   PubMed Web of Science ®Google Scholar
• Li Y, Yu Q, Ma LK, et al. Analysis of climacteric symptoms of perimenopausal women in Beijing city. J Reprod Med 2008;17:329–34
   Google Scholar
• Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012;15:105–14
   PubMed Web of Science ®Google Scholar
• Cen X, Heng W, Qinsheng G. Epidemiological survey of perimenopause. J Reprod Med 1993;1:23–7 [In Chinese]
   Google Scholar
• Xiaohong D, Songwen Z. Epidemiological investigation of the health status of perimenopausal women in Beijing. Med Sci Beijing 2002;24:235–8 [In Chinese]
   Google Scholar
• Ying L, Qi Y, Liangkun M, Zhengyi S. Analysis of climacteric symptoms of perimenopausal women in Beijing city. J Reprod Med 2008;17:329–34 [In Chinese]
   Google Scholar
• Hongxue L, Jianhua Z, Qi Y. Analysis of health status and health care needs of perimenopausal women in Harbin. Progress Modern Biomed 2012;21:4065–8 [In Chinese]
   Google Scholar
• Chundong L, Juan S, Changxu S, Qing C. Epidemiological investigation and analysis of perimenopausal syndrome among women in Chongqing. Chongqing Med 2015;28:3978–9 [In Chinese]
   Google Scholar
• Jalava-Broman J, Mäkinen J, Ojanlatva A, Jokinen K, Sillanmäki L, Rautava P. Change in the frequency of HRT use from 2000 to 2005 and reasons to discontinue: follow-up of a normal cohort in Finland. Acta Obstet Gynecol Scand 2011;90:351–7
   PubMed Web of Science ®Google Scholar
• Øren A. Motives for initiation, temporary discontinuation, and permanent discontinuation of hormone replacement therapy use among Norwegian women. Maturitas 2009;64:33–7
   PubMed Web of Science ®Google Scholar
• Ness J, Aronow WS, Newkirk E, McDanel D. Use of hormone replacement therapy by postmenopausal women after publication of the Women’s Health Initiative Trial. J Gerontol A Biol Sci Med Sci 2005;60:460–2
   PubMed Web of Science ®Google Scholar
• Blümel JE, Chedraui P, Barón G, et al. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI). Climacteric 2014;17:433–41
   PubMed Web of Science ®Google Scholar
• Leung TN, Haines CJ, Chung TK. Five-year compliance with hormone replacement therapy in postmenopausal Chinese women in Hong Kong. Maturitas 2001;39:195–201
   PubMed Web of Science ®Google Scholar
• Newton KM, Reed SD, Nekhyludov L, et al. Factors associated with successful discontinuation of hormone therapy. J Women’s Health 2014;23:382–8
   PubMed Web of Science ®Google Scholar
• Barber CA, Margolis K, Luepker RV, Arnett DK. The impact of the Women’s Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota heart survey (2000–2002). J Women’s Health 2004;13:975–85
   PubMed Web of Science ®Google Scholar
• Lan Y, Huang Y, Song Y, et al. Prevalence, severity, and associated factors of menopausal symptoms in middle-aged Chinese women: a community-based cross-sectional study in southeast China. Menopause 2017;24:1200–7
   PubMed Web of Science ®Google Scholar
• Jin F, Tao M, Teng Y, Shao H, Li C, Mills E. Knowledge and attitude towards menopause and hormone replacement therapy in Chinese women. Gynecol Obstet Invest 2015;79:40–5
   PubMed Web of Science ®Google Scholar
• Corrado F, D’Anna R, Caputo F, Cannata ML, Zoccali MG, Cancellieri F. Compliance with hormone replacement therapy in postmenopausal Sicilian women. Eur J Obstet Gynecol Reprod Biol 2005;118:225–8
   PubMed Web of Science ®Google Scholar
• Vihtamäki T, Savilahti R, Tuimala R. Why do postmenopausal women discontinue hormone replacement therapy? Maturitas 1999;33:99–105
   PubMed Web of Science ®Google Scholar
• Ruan X, Mueck AO. Chinese obstetrician-gynecologists still need more education in menopausal hormone therapy. Menopause 2014;21:1170–2
   PubMed Web of Science ®Google Scholar
• Jalava-Broman J, Mäkinen J, Ojanlatva A, Jokinen K, Sillanmäki L, Rautava P. Treatment of climacteric symptoms in Finland prior to the controversial reports on hormone therapy. Acta Obstet Gynecol Scand 2008;87:682–6
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang X, Li X, He X, Zhao Y. Knowledge and personal use of menopausal hormone therapy among Chinese obstetrician-gynecologists: results of a survey. Menopause 2014;21:1190–6
   PubMed Web of Science ®Google Scholar
• Beck KL, Anderson MC, Kirk JK. Transdermal estrogens in the changing landscape of hormone replacement therapy. Postgrad Med 2017;129:632–6
   PubMed Web of Science ®Google Scholar
• Cobin RH, Goodman NF. AACE Reproductive Endocrinology Scientific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause-2017 update. Endocr Pract 2017;23:869–80
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A. IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
   PubMed Web of Science ®Google Scholar
• Manson JE, Kaunitz AM. Menopause management–getting clinical care back on track. N Engl J Med 2016;374:803–6
   PubMed Web of Science ®Google Scholar